Australasian Psychiatry最新文献_第3页

Donanemab: The dawn of disease-modifying treatment for Alzheimer's disease in Australia. Donanemab：澳大利亚阿尔茨海默病改善治疗的曙光。

IF 1.2 4区医学

Australasian Psychiatry Pub Date : 2025-06-23 DOI: 10.1177/10398562251355157

Samantha M Loi, Matthew Jy Kang

引用次数: 0

Autoimmune neuropsychiatric sequelae of group A streptococcal infections in Aboriginal and Torres Strait Islander people: an overlooked burden? 原住民和托雷斯海峡岛民A群链球菌感染的自身免疫神经精神后遗症：一个被忽视的负担？

IF 1.2 4区医学

Australasian Psychiatry Pub Date : 2025-06-17 DOI: 10.1177/10398562251351462

Sarangan Ketheesan, Vicki Wade, Te-Yu Hung, Kathryn V Roberts

{"title":"Autoimmune neuropsychiatric sequelae of group A streptococcal infections in Aboriginal and Torres Strait Islander people: an overlooked burden?","authors":"Sarangan Ketheesan, Vicki Wade, Te-Yu Hung, Kathryn V Roberts","doi":"10.1177/10398562251351462","DOIUrl":"https://doi.org/10.1177/10398562251351462","url":null,"abstract":"ObjectiveWe highlight two autoimmune neuropsychiatric sequelae of group A streptococcal (GAS) infection that may cause disproportionate levels of psychiatric morbidity in Aboriginal and Torres Strait Islander people: Sydenham's Chorea (SC) and Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS). GAS infections, along with better characterised immune-mediated sequelae such as acute rheumatic fever and rheumatic heart disease, are highly prevalent in Aboriginal and Torres Strait Islander people, particularly in rural and remote communities, yet there is minimal information in the literature about the neuropsychiatric sequelae that might be expected. We suspect that there is an under-recognised burden of disease in these groups and seek to understand reasons for this.ConclusionsA multi-faceted, culturally attuned approach to better characterising and detecting the burden of these two conditions in Aboriginal and Torres Strait Islander people is required. Furthermore, larger scale clinical trials examining the efficacy of proposed treatments for SC and PANDAS are required to inform clinical guidelines.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562251351462"},"PeriodicalIF":1.2,"publicationDate":"2025-06-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144315788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Back to the future: A call to generalism in psychiatry. 回到未来：精神病学通才论的呼唤。

IF 1.2 4区医学

Australasian Psychiatry Pub Date : 2025-06-16 DOI: 10.1177/10398562251351507

Mathew Coleman, Beatriz Cuesta-Briand

{"title":"Back to the future: A call to generalism in psychiatry.","authors":"Mathew Coleman, Beatriz Cuesta-Briand","doi":"10.1177/10398562251351507","DOIUrl":"https://doi.org/10.1177/10398562251351507","url":null,"abstract":"IntroductionProviding a sustainably resourced medical workforce to meet the healthcare needs of a population is a significant challenge. Drivers of medical workforce issues include an ageing population, increasing chronic disease, skill shortages and workforce maldistribution. In this paper, we consider the imbalance between generalism and specialism in Australia, arguing that generalist positions may better address the current healthcare gaps.Analysis and evidenceWe describe generalism in the broad Australian healthcare system before exploring generalism within psychiatry and reflect on how lessons learned in rural generalist psychiatry can be applied to broader medical workforce reform.DiscussionThe imbalance between specialism and generalism within the mental health workforce across settings must be re-examined given the increased burden of disease and patient complexity. An explicit articulation and recognition of generalism within psychiatry may yield positive results on workforce development and ultimately accessibility of psychiatric services across geographical and service delivery settings.ConclusionAdvocating for generalist psychiatry, alongside general practice, to be at the centre of workforce solutions into the future is more critical than ever. The profession must give generalist psychiatry the recognition it deserves, lift its professional status and prioritise its training before we lose our authority and our social licence.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562251351507"},"PeriodicalIF":1.2,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144309490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Reflections on challenges and opportunities in attempting a clinical academic career. 对临床学术生涯的挑战与机遇的思考。

IF 1.2 4区医学

Australasian Psychiatry Pub Date : 2025-06-13 DOI: 10.1177/10398562251351505

Edward Miller, Yoon Kwon Choi, Michael Taran, Allen Huang, Katelyn Tadd, Tristan Bampton, Fiona Wilkes

引用次数: 0

Comorbid ADHD and Bipolar Disorder - An Update. ADHD和双相情感障碍共病。

IF 1.2 4区医学

Australasian Psychiatry Pub Date : 2025-06-13 DOI: 10.1177/10398562251351448

Gordon Parker

引用次数: 0

Antipsychotic prescription pattern in ASEAN: Comparison of antipsychotic prescription formulation and type from REAP-AP4 consortium study. 东盟抗精神病药物处方模式：来自REAP-AP4联合研究的抗精神病药物处方配方和类型的比较。

IF 1.2 4区医学

Australasian Psychiatry Pub Date : 2025-06-12 DOI: 10.1177/10398562251345320

Margarita M Maramis, Jakobus Gerick Pantouw, Isa Multazam Noor, Andi J Tanra, Pornjira Pariwatcharakul, Nopporn Tantirangsee, Kok Yoon Chee, Win Aung Myint, Tin Oo, Ee-Heok Kua, Tran Van Cuong, Shih-Ku Lin, Yu-Tao Xiang, Yang Shu-Yu, Lian Yu Chen, Tan Chay Hoon, Naotaka Shinfuku, Norman Sartorius, Takahiro A Kato, Kang Sim

{"title":"Antipsychotic prescription pattern in ASEAN: Comparison of antipsychotic prescription formulation and type from REAP-AP4 consortium study.","authors":"Margarita M Maramis, Jakobus Gerick Pantouw, Isa Multazam Noor, Andi J Tanra, Pornjira Pariwatcharakul, Nopporn Tantirangsee, Kok Yoon Chee, Win Aung Myint, Tin Oo, Ee-Heok Kua, Tran Van Cuong, Shih-Ku Lin, Yu-Tao Xiang, Yang Shu-Yu, Lian Yu Chen, Tan Chay Hoon, Naotaka Shinfuku, Norman Sartorius, Takahiro A Kato, Kang Sim","doi":"10.1177/10398562251345320","DOIUrl":"https://doi.org/10.1177/10398562251345320","url":null,"abstract":"BackgroundTo date, there has not been an evaluation of antipsychotic prescription practices specific to the Association of Southeast Asian Nations (ASEAN) region. This study examined antipsychotic prescription for schizophrenia patients in ASEAN countries based on Research on Asian Psychotropic Prescription (REAP) survey.MethodsThis study used data from the fourth REAP antipsychotic survey (REAP-AP4), conducted between March and May 2016 using standardized procedures. In total, 1817 adult schizophrenia patients from six ASEAN countries were analysed.ResultsPrescription formulation was significantly associated with illness duration (G (24) = 150.595, p < .001) and prescribing country (G (20) = 571.423, p < .001). Oral antipsychotic monotherapy was the most common prescription across all illness durations, with a decreasing trend from 3-6 months to 10-20 years. Oral antipsychotic monotherapy was also the most commonly used prescription in almost all countries. The frequency of long-acting injection (LAI)-oral combination antipsychotic prescription increased with the patient's illness duration and is more commonly prescribed in Malaysia, Singapore, and Thailand.ConclusionLAI-oral combination antipsychotics were prescribed more frequently within patients with longer duration of illness in more developed countries. Antipsychotic monotherapy and oral antipsychotic prescriptions were prevalent across all illness durations and in most ASEAN countries.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562251345320"},"PeriodicalIF":1.2,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144282297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Response to: RANZCP Position Statement 46: A missed opportunity to provide sophisticated guidance on asylum seeker and refugee policy. RANZCP立场声明46：错失了为寻求庇护者和难民政策提供复杂指导的机会。

IF 1.2 4区医学

Australasian Psychiatry Pub Date : 2025-06-11 DOI: 10.1177/10398562251351439

Suresh Sundram, Kym Jenkins, Tram Nguyen

引用次数: 0

'I, robot, can help you'. Applications of Generative Artificial Intelligence in RANZCP psychiatry training. “我，机器人，可以帮助你。”生成式人工智能在RANZCP精神病学培训中的应用。

IF 1.2 4区医学

Australasian Psychiatry Pub Date : 2025-06-08 DOI: 10.1177/10398562251344470

Shane Gill, Cherrie Galletly Oam

{"title":"'I, robot, can help you'. Applications of Generative Artificial Intelligence in RANZCP psychiatry training.","authors":"Shane Gill, Cherrie Galletly Oam","doi":"10.1177/10398562251344470","DOIUrl":"https://doi.org/10.1177/10398562251344470","url":null,"abstract":"ObjectiveThe growing availability and sophistication of online generative artificial intelligence (GenAI) tools, such as ChatGPT, necessitates an exploration of their applications within the RANZCP Fellowship Training Program. This article examines how GenAI could be integrated into various areas, including trainee selection, workplace-based assessments, the Scholarly Project (SP), and the Psychotherapy Written Case (PWC). While GenAI offers benefits, trainees must understand that there are limitations on how these can be used with patient data. They should also be aware of the ethical and legal considerations surrounding the use of purpose-built medical scribe programs. For this paper, ChatGPT was employed to enhance language quality, without contributing to content generation.ConclusionThe accessibility and ease of use of GenAI present both opportunities and challenges. Given the limitations of AI detection software, the RANZCP will need to adapt to GenAI rather than attempt to regulate its use. Revisions to assessment methods, particularly those relying on written assignments, will be needed. As this is a rapidly evolving field, training programs should be continually updated to remain relevant.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562251344470"},"PeriodicalIF":1.2,"publicationDate":"2025-06-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144246209","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Moving away from cosmetic psychiatry and toward eudaimonic psychiatry. 从美容精神病学转向幸福精神病学。

IF 1.2 4区医学

Australasian Psychiatry Pub Date : 2025-06-06 DOI: 10.1177/10398562251347920

Brendan Daugherty

引用次数: 0

A systematic review of the treatments of anxiety in children with autism spectrum disorder. 自闭症谱系障碍儿童焦虑治疗的系统回顾。

IF 1.2 4区医学

Australasian Psychiatry Pub Date : 2025-06-04 DOI: 10.1177/10398562251346614

Humaira Khaleeq, Mohsin Malik, Victoria Harpwood

{"title":"A systematic review of the treatments of anxiety in children with autism spectrum disorder.","authors":"Humaira Khaleeq, Mohsin Malik, Victoria Harpwood","doi":"10.1177/10398562251346614","DOIUrl":"https://doi.org/10.1177/10398562251346614","url":null,"abstract":"ObjectivesAnxiety symptoms are frequently observed in children with autism spectrum disorder (ASD). While there is substantial research on treatment options for anxiety in typically developing (TD) children, there is a significant gap in understanding the management of anxiety in children with ASD. The aim of this review is to evaluate the evidence base of current research on various treatments for anxiety in children under 18 years of age with ASD, assess the effectiveness of these interventions, and examine the potential adverse effects associated with these treatment options to inform clinical practice and caregiver decisions.MethodsA systematic literature review was conducted using the databases Scopus, PubMed, and MEDLINE. The search employed relevant keywords to identify articles published between 2014 and 2023 (inclusive). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were adhered to throughout the review process.ResultsA total of 33 studies met the inclusion criteria for this review. Significant heterogeneity was observed in the methodologies of the included studies, including variations in assessment of anxiety, measures of treatment response, treatment duration, and follow-up periods. Cognitive Behavior Therapy (CBT) emerged as the most evidence-based treatment for managing anxiety in autistic children. Notably, adapted CBT specifically designed for children with ASD demonstrated superior outcomes compared to standard CBT approaches. There is a notable lack of pharmacological studies addressing anxiety in this population.ConclusionFurther research is essential to address the gaps in treatments available for managing anxiety in autistic children. Moreover, the development of sophisticated and customized anxiety measurement scales specifically designed for autistic children would enhance the validity and reliability of future research.","PeriodicalId":8630,"journal":{"name":"Australasian Psychiatry","volume":" ","pages":"10398562251346614"},"PeriodicalIF":1.2,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144214719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0